Funding Received

CSIR-Aspire

Dual BBB and Glioma Targeting Chimeric- Peptide Decorated-Anisotropic Gold Nanoroses for Combined Chemo, Photo, and RNAi (shRNA) mediated Therapy in Glioblastoma.

Funding Amount: ₹ 29,97,560

Department of Science and Technology (DST),

INSPIRE Faculty Award,

01/07/2014-30/06/2019

Development of Versatile, Multifunctional and Adaptable Peptide Nanofiber Scaffolds with Potential for Promoting Neuritogenesis in Brain Injury.

Funding Amount: ₹ 3500000

DST, NanomissionDevelopment of novel theranostic nanoplatforms for targeted combination therapy for liver cancers.

DBT Biocare

(28/6/17 – 27/6/2020)

Multimodal Glioblastoma Therapy by Blood Brain Barrier Traversing and Glioma Targeting Anti-cancer Peptide Theranostic Nanoparticles.

Funding Amount: ₹ 5200000

DST-SERB

20/07/2022 to 19/07/2025

Photo-theranostic catecholamine-bdnf-protein hybrid nanocomplexes for multifacetedand effective Alzheimer's therapy.

Funding Amount: ₹ 4066416

ICMR

12/02/2024 - 11/02/2028

Non-invasive and in situ forming peptide polymer hydrogel containing CPP decorated nanoparticles/photoresponsive

agents with crystallin aggregate disaggregating propensity for potential cataract therapy.

Amount: ₹ 23762935

DBT

01/09/2021 to 31/08/2024

Hierarchically Organized Amino Acid/protein Core-Shell Nanostructures With 2 Photon Responsive off-on Switchable Lids for Light Activable Delivery of an Array of Anti-miRNA Therapeutics in Glioblastoma.

Amount : ₹ 5900000

DBT

1/12/2021 to 30/11/2024

Enhanced osteogenesis promoted bybone injury specific co-delivery of BMP2 and Noggin Si-RNA loaded inmicrofluidically fabricated aminoacid-based nanobowls with pHtunable lids.Amount : ₹ 4000000

CSIR

6/7/2023 - 5/7/2026

Blood brain barrier targeting and lysosome directed targeting catecholamine poly dot based theragnostic nano-systems for enhanced therapy of Alzheimer's disease as exemplified in a zebra fish model.

Amount : ₹ 1800000

​